From: A high-throughput and sensitive method to measure Global DNA Methylation: Application in Lung Cancer
 |  |  |  | Pathology |  | |||
---|---|---|---|---|---|---|---|---|
Patient ID | Age | Race | Gender | Tumor | Lymph Node | Metastasis | Stage | Differentiation |
1 | 64 | White | Male | T2 | N0 | Mx | Stage IB | Non-well Diff |
2 | 59 | White | Female | T1 | N0 | M0 | Stage IA | Non-well Diff |
3 | 85 | White | Female | T1 | N0 | M0 | Stage IA | Non-well Diff |
4 | 62 | White | Male | T1 | N0 | Mx | Stage IA | Well Diff |
5 | 62 | White | Male | T1 | N1 | Mx | Stage IIB | Non-well Diff |
6 | 53 | White | Male | T1 | N0 | M1 | Stage IA | N/A |
7 | 68 | White | Female | T1 | N0 | Mx | Stage IA | Well Diff |
8 | 60 | Black | Female | T1 | N0 | M0 | Stage IA | Non-well Diff |
9 | 54 | White | Male | T2 | N0 | Mx | Stage IB | Non-well Diff |
10 | 77 | White | Female | T2 | N0 | M0 | Stage IA | Non-well Diff |
11 | 71 | White | Female | T1 | N2 | M1 | Stage IIIA | Well Diff |
12 | 47 | Black | Female | T3 | N/A | N/A | Stage IIIA | N/A |
13 | 57 | White | Female | T4 | N0 | M0 | Stage IB | Non-well Diff |
14 | 65 | White | Female | T1 | N0 | M0 | Stage IA | Non-well Diff |
15 | 77 | White | Male | T2 | N0 | M0 | Stage IB | Non-well Diff |
16 | 82 | White | Male | T1 | N0 | Mx | Stage IA | Non-well Diff |
17 | 85 | White | Male | T2 | N0 | Mx | Stage IB | Non-well Diff |
18 | 52 | White | Male | T2 | N0 | M0 | Stage IB | Non-well Diff |
19 | 63 | White | Male | T2 | N0 | M0 | Stage IA | Non-well Diff |
20 | 56 | White | Male | T2 | N0 | M0 | Stage IB | Non-well Diff |